(Q44144740)

English

The paraoxonase-1 codon 192 polymorphism is associated with fasting total cholesterol and LDL-cholesterol concentrations only in postmenopausal women. The REGICOR study

scientific article published in July 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

The paraoxonase-1 codon 192 polymorphism is associated with fasting total cholesterol and LDL-cholesterol concentrations only in postmenopausal women. The REGICOR study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

6

object named as

Jaume Marrugat

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Mariano Senti

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Marta Tomás

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Roberto Elosual

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Joan Sala

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Rafel Masiá

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

677-683

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Gerona, Spain, 1990-1992. REGICOR Investigators.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

A questionnaire for the assessment of leisure time physical activities

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

The molecular basis of the human serum paraoxonase activity polymorphism.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish Women

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Paraoxonase and coronary heart disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2002.116

21 January 2018

Identifiers

10.1515/CCLM.2002.116

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44144740&oldid=2107100903"